151 related articles for article (PubMed ID: 20089948)
1. Patch instead of pill: a safer menopausal estrogen?
Cushman M
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):136-7. PubMed ID: 20089948
[No Abstract] [Full Text] [Related]
2. Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.
Canonico M; Fournier A; Carcaillon L; Olié V; Plu-Bureau G; Oger E; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Scarabin PY
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):340-5. PubMed ID: 19834106
[TBL] [Abstract][Full Text] [Related]
3. Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.
Scarabin PY; Hemker HC; Clément C; Soisson V; Alhenc-Gelas M
Menopause; 2011 Aug; 18(8):873-9. PubMed ID: 21487317
[TBL] [Abstract][Full Text] [Related]
4. Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.
Kaunitz AM
Menopause; 2012 Jun; 19(6):602-3. PubMed ID: 22549171
[No Abstract] [Full Text] [Related]
5. [Hormone therapy and risk for venous thromboembolism in postmenopausal women].
Lacut K; Oger E
Rev Prat; 2005 Feb; 55(4):389-92. PubMed ID: 15828617
[TBL] [Abstract][Full Text] [Related]
6. Further evidence for promoting transdermal estrogens in the management of postmenopausal symptoms.
Canonico M; Scarabin PY
Menopause; 2011 Oct; 18(10):1038-9. PubMed ID: 21946050
[No Abstract] [Full Text] [Related]
7. Hormone therapy and hemostasis among postmenopausal women: a review.
Canonico M
Menopause; 2014 Jul; 21(7):753-62. PubMed ID: 24937030
[TBL] [Abstract][Full Text] [Related]
8. Type of hormone replacement therapy and risk of venous thromboembolism.
Roberts H
BMJ; 2008 May; 336(7655):1203-4. PubMed ID: 18495630
[TBL] [Abstract][Full Text] [Related]
9. Synergism between non-O blood group and oral estrogen in the risk of venous thromboembolism among postmenopausal women: The ESTHER study.
Canonico M; Olié V; Carcaillon L; Tubert-Bitter P; Scarabin PY;
Thromb Haemost; 2008 Jan; 99(1):246-8. PubMed ID: 18217166
[No Abstract] [Full Text] [Related]
10. [Hormone replacement therapy and venous thromboembolism].
Pavičić Baldani D; Skrgatić L; Simunić V; Elvedi Gasparović V; Geršak B
Lijec Vjesn; 2015; 137(1-2):34-40. PubMed ID: 25906547
[TBL] [Abstract][Full Text] [Related]
11. Hormones and venous thromboembolism among postmenopausal women.
Scarabin PY
Climacteric; 2014 Dec; 17 Suppl 2():34-7. PubMed ID: 25223916
[TBL] [Abstract][Full Text] [Related]
12. Progestogens and venous thromboembolism in menopausal women: an updated oral versus transdermal estrogen meta-analysis.
Scarabin PY
Climacteric; 2018 Aug; 21(4):341-345. PubMed ID: 29570359
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen, hormone receptors and hormone replacement therapy in women previously treated for breast cancer: a cohort study.
Dew JE; Wren BG; Eden JA
Climacteric; 2002 Jun; 5(2):151-5. PubMed ID: 12051110
[TBL] [Abstract][Full Text] [Related]
14. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M; Scarabin PY
Climacteric; 2009; 12 Suppl 1():76-80. PubMed ID: 19811247
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy and risk of venous thromboembolism among postmenopausal women.
Canonico M
Maturitas; 2015 Nov; 82(3):304-7. PubMed ID: 26276103
[TBL] [Abstract][Full Text] [Related]
16. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.
Canonico M; Oger E; Plu-Bureau G; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2007 Feb; 115(7):840-5. PubMed ID: 17309934
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and thrombotic risk: beauty is only skin deep.
Rosendaal FR
Nat Clin Pract Cardiovasc Med; 2008 Nov; 5(11):684-5. PubMed ID: 18797429
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
19. EMAS position statement: Managing the menopause in the context of coronary heart disease.
Schenck-Gustafsson K; Brincat M; Erel CT; Gambacciani M; Lambrinoudaki I; Moen MH; Tremollieres F; Vujovic S; Rozenberg S; Rees M;
Maturitas; 2011 Jan; 68(1):94-7. PubMed ID: 21156341
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-progestin increases breast cancer risk.
Stephens MB
J Fam Pract; 2000 Apr; 49(4):301-2. PubMed ID: 10778832
[No Abstract] [Full Text] [Related]
[Next] [New Search]
